🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

RecruitingPhase 4Ages 18 Years - 50 YearsFemaleWestern Galilee Hospital-Nahariya
NCT06061393 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: pregnancy\>24 weeks of gestation anemia with Hb\<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage Exclusion Criteria: * Allergy to one of the study's drugs * IV iron treatment in the last month * Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis * Twin pregnancy * non iron deficiency anemia
💊

What it tests

  • Venofer 200 MG Per 10 ML Injection
  • Ferinject
📍

Where

1 site
Galilee Medical Center
Nahariya, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy